AKT1 and atherosclerosis: Therefore, it can be concluded that evodiamine may inhibit the activation of the PI3K/Akt axis in atherosclerotic VSMCs and reduce the level of inflammatory response and oxidative stress, thus delaying the process of atherosclerosis.